Enhancing Therapeutic Efficacy of Cinnamon Essential Oil by Nanoemulsification for Intravaginal Treatment of Candida Vaginitis
Yi-Ting Lin,Wei-Chung Tsai,Hsueh-Yu Lu,Shih-Yuan Fang,Hsiang-Wen Chan,Chung-Hsiung Huang
DOI: https://doi.org/10.2147/ijn.s458593
IF: 7.033
2024-05-29
International Journal of Nanomedicine
Abstract:Yi-Ting Lin, 1 Wei-Chung Tsai, 1 Hsueh-Yu Lu, 1 Shih-Yuan Fang, 1 Hsiang-Wen Chan, 1 Chung-Hsiung Huang 1, 2 1 Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan; 2 Center for Marine Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 20224, Taiwan Correspondence: Chung-Hsiung Huang, Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan, Tel +886-2-2462-2192 ext. 5116, Email Background: Due to its prevalence, recurrence, and the emergence of drug-resistance, Candida vaginitis significantly impacts the well-being of women. Although cinnamon essential oil (CEO) possesses antifungal activity, its hydrophobic properties limit its clinical application. Purpose: To overcome this challenge, a nanoemulsification technology was employed to prepare cinnamon essential oil-nanoemulsion (CEO@NE), and its therapeutic efficacy and action mechanism for Candida vaginitis was investigated in vivo and in vitro. Materials and Methods: CEO@NE, composed of 4% CEO, 78% distilled water, and 18% Tween 80, was prepared by ultrasonic nanoemulsification. The physical properties, anti- Candida activity, cytotoxicity, immunomodulatory potential and storage stability of CEO@NE were explored. Subsequently, the effect of intravaginal CEO@NE treatment on Candida vaginitis was investigated in mice. To comprehend the possible mechanism of CEO@NE, an analysis was conducted to ascertain the production of intracellular reactive oxygen species (ROS) in C. albicans . Results: CEO@NE, with the droplet size less than 100 nm and robust storage stability for up to 8 weeks, exhibited comparable anti- Candida activity with CEO. CEO@NE at the concentration lower than 400 μg/mL had no cytotoxic and immunomodulatory effects on murine splenocytes. Intravaginal treatment of CEO@NE (400 μg/mL, 20 μL/day/mouse for 5 consecutive days) curbed Candida colonization, ameliorated histopathological changes, and suppressed inflammatory cytokine production in mice intravaginally challenged with C. albicans . Notably, this treatment preserved the density of vaginal lactic acid bacteria (LAB) crucial for vaginal health. Co-culturing C. albicans with CEO@NE revealed concentration-dependent augmentation of intracellular ROS generation and ensuing cell death. In addition, co-culturing LPS-stimulated murine splenocytes with CEO@NE yielded a decrease in the generation of cytokines. Conclusion: This discovery provides insight into the conceivable antifungal and anti-inflammatory mechanisms of CEO@NE to tackle Candida vaginitis. CEO@NE offers a promising avenue to address the limitations of current treatments, providing novel strategy for treating Candida vaginitis. Keywords: anti-inflammation, Candida vaginitis, cinnamon essential oil, nanoemulsion, reactive oxygen species Candida albicans , a prevalent yeast species, stands as a potential threat due to its ability to induce opportunistic infections. Among the healthy individuals, 39% are carriers of yeast, with 89% being colonized by C. albicans . 1 Normally, it maintains a symbiotic relationship with the human body. However, under conditions of compromised immune function, C. albicans can overgrow and initiate candidiasis. Notably, C. albican s ranks as the most common pathogenic species within the Candida genus, and C. albicans infections typically manifest in localized mucosal areas such as the oral cavity, esophagus, and vagina. Each year, candidiasis impacts over 250,000 individuals and is linked to a mortality rate surpassing 70%. 2 C. albicans possesses well-documented pathogenic attributes, including its ability to adhere to epithelial cells, and the formation of hyphae. 3 Upon infecting and adhering to mucosal tissue, C. albicans hyphae can infiltrate epithelial cells. Within the tissue, dendritic cells phagocytize the pathogen and present it to CD4 + T helper (Th) cells. This engagement promotes the differentiation of Th1 and Th17 cells, leading to the production of IFN-γ and IL-17, coordinating the eradication of the pathogen. 4 However, C. albicans not only inflicts direct damage to vaginal tissue but also incites an inflammatory response. After invading vaginal tissue, the initiation of signaling pathways occurs, resulting in the generation of pro-inflammatory substances like TNF-α and IL-6. Consequently, this triggers the secretion of diverse cytokines, chemokines, and the chemotaxis of neutrophils to the site of infec -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology